Sector ratings Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 18/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +6.67% |
|
+3.97% | +4.73% |
| 19/08 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 31Cr | - | BBB | - | - | ||||
| 4.59TCr | AAA | |||||||
| 4.42TCr | AAA | |||||||
| 4.2TCr | - | B | - | - | ||||
| 3.96TCr | - | |||||||
| 3.11TCr | A | |||||||
| 1.72TCr | BBB | |||||||
| 1.63TCr | - | - | - | - | ||||
| 1.5TCr | AA | |||||||
| 1.34TCr | AAA | |||||||
| 1.31TCr | AA | |||||||
| 1.26TCr | A | - | ||||||
| 1.13TCr | AA | |||||||
| 1.08TCr | AA | |||||||
| 909.73Cr | - | BBB | - | - | ||||
| 967.29Cr | - | BBB | - | - | ||||
| 924.29Cr | BB | - | ||||||
| 907.65Cr | AA | - | ||||||
| 887.17Cr | AAA | |||||||
| 862.7Cr | - | B | - | - | ||||
| Average | 1.84TCr | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
